Treatment Set TS345268 is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Ambrosia Artemisiifolia Pollen; Ambrosia Trifida Pollen.
| Product ID | 49288-0843_9a8e59e8-156a-4999-a000-b68054b405d3 |
| NDC | 49288-0843 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Treatment Set TS345268 |
| Generic Name | Treatment Set Ts345268 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1986-10-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN |
| Active Ingredient Strength | 20000 [AU]/mL; g/mL |
| Pharm Classes | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1986-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1986-10-31 |
| Inactivation Date | 2019-11-13 |
| Ingredient | Strength |
|---|---|
| AMBROSIA ARTEMISIIFOLIA POLLEN | 20000 [AU]/mL |
| SPL SET ID: | 354ef6d9-c531-4958-bc94-00e52569c0e1 |
| Manufacturer | |
| UNII |
|
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| NUI Code |